BATE KENNETH
SEC insider (Form 3/4/5 filer). CIK 0001210238. Director at Astria Therapeutics, Inc. (ATXS) and 1 other issuer. 40 reported Form 4/5 transactions since Sep 2024; latest on Jan 23, 2026. Located in BOSTON, MA.
Companies BATE KENNETH has filed insider reports for
- Astria Therapeutics, Inc. (ATXS): Director
- MADRIGAL PHARMACEUTICALS, INC. (MDGL): Director
BATE KENNETH
CIK: 0001210238
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (40 total)
- Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
14.1K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
16.7K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
14.1K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
26.6K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
8.3K shares- - Nov 5, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect1.3K shares at avg. $482.41$619K - Nov 5, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect3.3K shares at avg. $481.13$1.6M - Nov 5, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
ExerciseDirect10K shares at avg. $303.79$3.0M - Nov 5, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect1K shares at avg. $485.54$489K - Nov 5, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect1.8K shares at avg. $480.24$847K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 23, 2026 |  ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 14,100 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 16,666 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 14,100 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 26,550 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 8,333 | - | - | Direct |
| Nov 5, 2025 |  MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 1,284 | $482.41 | $619,417 | Direct |
| Nov 5, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 3,259 | $481.13 | $1,567,995 | Direct |
| Nov 5, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Exercise | 10,000 | $303.79 | $3,037,900 | Direct |
| Nov 5, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 1,008 | $485.54 | $489,421 | Direct |
| Nov 5, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 1,763 | $480.24 | $846,663 | Direct |
1-10 of 40 transactions